Natural thiopeptides as a privileged scaffold for drug discovery and therapeutic development

被引:0
|
作者
Xiaoqi Shen
Muhammad Mustafa
Yanyang Chen
Yingying Cao
Jiangtao Gao
机构
[1] Fujian Agriculture and Forestry University,College of Life Sciences
来源
关键词
Thiopeptides; Natural products; Antimicrobial activity; Biosynthesis;
D O I
暂无
中图分类号
学科分类号
摘要
Since the start of the 21st century, antibiotic drug discovery and development from natural products has experienced a certain renaissance. Currently, basic scientific research in chemistry and biology of natural products has finally borne fruit for natural product-derived antibiotics drug discovery. A batch of new antibiotic scaffolds were approved for commercial use, including oxazolidinones (linezolid, 2000), lipopeptides (daptomycin, 2003), and mutilins (retapamulin, 2007). Here, we reviewed the thiazolyl peptides (thiopeptides), an ever-expanding family of antibiotics produced by Gram-positive bacteria that have attracted the interest of many research groups thanks to their novel chemical structures and outstanding biological profiles. All members of this family of natural products share their central azole substituted nitrogen-containing six-membered ring and are classified into different series. Most of the thiopeptides show nanomolar potencies for a variety of Gram-positive bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and penicillin-resistant Streptococcus pneumonia (PRSP). They also show other interesting properties such as antiplasmodial and anticancer activities. The chemistry and biology of thiopeptides has gathered the attention of many research groups, who have carried out many efforts towards the study of their structure, biological function, and biosynthetic origin. Here we reviewed a total of 119 natural thiopeptides discovered during the last 50 years. Moreover, we summarized biological profiles, mechanisms of action, and biosynthesis of these thiopeptides.
引用
收藏
页码:1063 / 1098
页数:35
相关论文
共 50 条
  • [21] Natural product derived privileged scaffolds in drug discovery
    Davison, Emma K.
    Brimble, Margaret A.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2019, 52 : 1 - 8
  • [22] Design, synthesis, and evaluation of a new privileged scaffold for use in drug discovery
    Stocks, Michael
    Schwehm, Carolin
    Kellam, Barrie
    Garces, Aimie
    Kindon, Nicholas
    Bradshaw, Tracey
    Li, Jin
    MacDonald, Simon
    Rowedder, James
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [23] Coumarins as privileged scaffold for anti-inflammatory drug development
    Grover, Jagdeep
    Jachak, Sanjay M.
    RSC ADVANCES, 2015, 5 (49) : 38892 - 38905
  • [24] Thiazolo[4,5-d]pyrimidines as a privileged scaffold in drug discovery
    Kuppast, Bhimanna
    Fahmy, Hesham
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 113 : 198 - 213
  • [25] Recent report on indoles as a privileged anti-viral scaffold in drug discovery
    Singh, Asmita
    Bhutani, Charu
    Khanna, Pankaj
    Talwar, Sangeeta
    Singh, Sandeep Kumar
    Khanna, Leena
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 281
  • [26] Thiazolopyrimidine, a privileged scaffold: Recent updates on synthetic and pharmacological perspective in drug discovery
    Khator, Rakesh
    Monga, Vikramdeep
    ARCHIV DER PHARMAZIE, 2025, 358 (03)
  • [27] Anthraquinones as a privileged scaffold in drug discovery targeting nucleotide-binding proteins
    Baqi, Younis
    DRUG DISCOVERY TODAY, 2016, 21 (10) : 1571 - 1577
  • [28] Tetrazole: A privileged scaffold for the discovery of anticancer agents
    Verma, Anil
    Kaur, Balwinder
    Venugopal, Sneha
    Wadhwa, Pankaj
    Sahu, Sanjeev
    Kaur, Paranjeet
    Kumar, Deepak
    Sharma, Ajit
    CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 100 (03) : 419 - 442
  • [29] Recent contribution of medicinally active 2-aminothiophenes: A privileged scaffold for drug discovery
    Duvauchelle, Valentin
    Meffre, Patrick
    Benfodda, Zohra
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 238
  • [30] Nitroheterocyclic derivatives: privileged scaffold for drug development against Chagas disease
    Cauê Benito Scarim
    Chung Man Chin
    Medicinal Chemistry Research, 2019, 28 : 2099 - 2108